Converge Technology Solutions Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Converge Technology Solutions heeft een totaal eigen vermogen van CA$383.7M en een totale schuld van CA$331.7M, wat de schuld-eigenvermogensverhouding op 86.4% brengt. De totale activa en totale passiva bedragen respectievelijk CA$2.1B en CA$1.7B. De EBIT Converge Technology Solutions is CA$54.2M waardoor de rentedekking 1.4 is. Het heeft contanten en kortetermijnbeleggingen van CA$173.8M.
Belangrijke informatie
86.4%
Verhouding schuld/eigen vermogen
CA$331.68m
Schuld
| Rente dekkingsratio | 1.4x |
| Contant | CA$173.82m |
| Aandelen | CA$383.69m |
| Totaal verplichtingen | CA$1.68b |
| Totaal activa | CA$2.06b |
Recente financiële gezondheidsupdates
Is Converge Technology Solutions (TSE:CTS) Using Too Much Debt?
Sep 04
We Think Converge Technology Solutions (TSE:CTS) Is Taking Some Risk With Its Debt
May 23Is Converge Technology Solutions (TSE:CTS) Using Too Much Debt?
Nov 08Converge Technology Solutions (TSE:CTS) Has A Pretty Healthy Balance Sheet
Nov 29Converge Technology Solutions (TSE:CTS) Has A Pretty Healthy Balance Sheet
Aug 29Recent updates
Is Converge Technology Solutions (TSE:CTS) Using Too Much Debt?
Sep 04Pinning Down Converge Technology Solutions Corp.'s (TSE:CTS) P/S Is Difficult Right Now
Jun 21We Think Converge Technology Solutions (TSE:CTS) Is Taking Some Risk With Its Debt
May 23Is Converge Technology Solutions Corp. (TSE:CTS) Trading At A 49% Discount?
May 02Capital Allocation Trends At Converge Technology Solutions (TSE:CTS) Aren't Ideal
Apr 11Converge Technology Solutions Corp. (TSE:CTS) Held Back By Insufficient Growth Even After Shares Climb 28%
Mar 16Converge Technology Solutions Corp.'s (TSE:CTS) Share Price Is Matching Sentiment Around Its Revenues
Jan 31Is Converge Technology Solutions (TSE:CTS) Using Too Much Debt?
Nov 08Some Investors May Be Worried About Converge Technology Solutions' (TSE:CTS) Returns On Capital
Oct 18Should You Investigate Converge Technology Solutions Corp. (TSE:CTS) At CA$2.59?
Aug 11Here's What's Concerning About Converge Technology Solutions' (TSE:CTS) Returns On Capital
May 31Is There Now An Opportunity In Converge Technology Solutions Corp. (TSE:CTS)?
May 11We Like These Underlying Return On Capital Trends At Converge Technology Solutions (TSE:CTS)
Feb 11Should You Be Adding Converge Technology Solutions (TSE:CTS) To Your Watchlist Today?
Jan 20Is Now The Time To Look At Buying Converge Technology Solutions Corp. (TSE:CTS)?
Jan 04Converge Technology Solutions (TSE:CTS) Has A Pretty Healthy Balance Sheet
Nov 29Converge Technology Solutions (TSE:CTS) Is Looking To Continue Growing Its Returns On Capital
Oct 04We Ran A Stock Scan For Earnings Growth And Converge Technology Solutions (TSE:CTS) Passed With Ease
Sep 16Converge Technology Solutions (TSE:CTS) Has A Pretty Healthy Balance Sheet
Aug 29Converge Technology Solutions Corp.'s (TSE:CTS) 32% Jump Shows Its Popularity With Investors
Aug 11Converge Technology Solutions (TSE:CTS) Shareholders Will Want The ROCE Trajectory To Continue
Jun 28Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( CA$1.2B ) CTS } overtreffen de korte termijn passiva ( CA$1.2B ).
Langlopende schulden: De kortetermijnactiva CTS ( CA$1.2B ) overtreffen de langetermijnschulden ( CA$514.2M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 41.1% ) CTS wordt als hoog beschouwd.
Schuld verminderen: CTS had 5 jaar geleden een negatief eigen vermogen, maar is nu positief en is dus verbeterd.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: Terwijl het verlieslatende CTS voldoende cash runway heeft voor meer dan 3 jaar, als het zijn huidige positieve vrije kasstroom-niveau behoudt.
Voorspelling contante baan: CTS is verlieslatend, maar heeft voldoende kasmiddelen voor meer dan 3 jaar, omdat de vrije kasstroom positief is en met 51.1 % per jaar groeit.